Sinha, Gunjan <br/><br/>
Roche bets on alpha-synuclein for Parkinson's.  [electronic resource] 

 -  Nature biotechnology  Mar 2014 
 - 212 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1546-1696 
<br/><br/><label>Standard No.: </label>10.1038/nbt0314-212a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Biomedical Research<br/>Drug Industry<br/>Humans<br/>Parkinson Disease--drug therapy<br/>alpha-Synuclein--therapeutic use